Enhancing immune effects of a DNA vaccine against kidney cancer using CD40L as an adjuvant. Braz. J. Pharm. Sci. [Internet]. 2019 Dec. 5 [cited 2024 Jun. 2];55:e18173. Available from: https://www.periodicos.usp.br/bjps/article/view/164799